Tumors exposed to acute cyclic hypoxia show increased vessel density and delayed blood supply

Microvascular Research

Volumn 85, Issue 1, 2013, Pages 10-15

  Gaustad, Jon Vidar ^a   Simonsen, Trude Golimo ^a   Roa, Ana Maria Acosta ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

GFP; TRITC; VEGF

Indexed keywords

ACUTE CYCLIC HYPOXIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; CANCER GROWTH; CANCER MORPHOLOGY; CANCER SIZE; CELL HETEROGENEITY; CONTROLLED STUDY; DENSITY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; MELANOMA; MOUSE; MULTICELLULAR SPHEROID; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REACTION TIME; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; ANOXIA; BLOOD VESSELS; CELL HYPOXIA; CELL LINE, TUMOR; DEXTRANS; FEMALE; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; RHODAMINES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84871715274     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.11.002     Document Type: Article

References (34)

1. Brizel D.M., Dodge R.K., Clough R.W., Dewhirst M.W. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother. Oncol. 1999, 53:113-117.
2. Brown J.M. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res. 1999, 59:5863-5870.
3. Brurberg K.G., Gaustad J.V., Mollatt C.S., Rofstad E.K. Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia 2008, 10:727-735.
4. Cairns R.A., Hill R.P. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res. 2004, 64:2054-2061.
5. Cairns R.A., Kalliomaki T., Hill R.P. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 2001, 61:8903-8908.
6. Chaplin D.J., Durand R.E., Olive P.L. Acute hypoxia in tumors: implications for modifiers of radiation effects. Int. J. Radiat. Oncol. Biol. Phys. 1986, 12:1279-1282.
7. Chaudary N., Hill R.P. Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Lab. Invest. 2009, 89:587-596.
8. Chaudary N., Milosevic M., Hill R.P. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecol. Oncol. 2011, 123:393-400.
9. Dewhirst M.W., Kimura H., Rehmus S.W., Braun R.D., Papahadjopoulos D., Hong K., Secomb T.W. Microvascular studies on the origins of perfusion-limited hypoxia. Br. J. Cancer Suppl. 1996, 27:S247-S251.
10. Dewhirst M.W., Cao Y., Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 2008, 8:425-437.
11. Durand R.E., Sham E. The lifetime of hypoxic human tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:711-715.
12. Gaustad J.V., Brurberg K.G., Simonsen T.G., Mollatt C.S., Rofstad E.K. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 2008, 10:354-362.
13. Gaustad J.V., Simonsen T.G., Brurberg K.G., Huuse E.M., Rofstad E.K. Blood supply in melanoma xenografts is governed by the morphology of the supplying arteries. Neoplasia 2009, 11:277-285.
14. Gaustad J.V., Simonsen T.G., Leinaas M.N., Rofstad E.K. Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts. BMC Cancer 2012, 12:388.
15. Höckel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 2001, 93:266-276.
16. Jain R.K. Determinants of tumor blood flow: a review. Cancer Res. 1988, 48:2641-2658.
17. Jain R.K., Munn L.L., Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2002, 2:266-276.
18. Kalliomaki T.M., McCallum G., Lunt S.J., Wells P.G., Hill R.P. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer 2008, 8:151.
19. Kimura H., Braun R.D., Ong E.T., Hsu R., Secomb T.W., Papahadjopoulos D., Hong K., Dewhirst M.W. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 1996, 56:5522-5528.
20. Nordsmark M., Alsner J., Keller J., Nielsen O.S., Jensen O.M., Horsman M.R., Overgaard J. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br. J. Cancer 2001, 84:1070-1075.
21. Øye K.S., Gulati G., Graff B.A., Gaustad J.V., Brurberg K.G., Rofstad E.K. A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber. Microvasc. Res. 2008, 75:179-187.
22. Rofstad E.K. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer 1994, 70:804-812.
23. Rofstad E.K. Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 2000, 76:589-605.
24. Rofstad E.K., Halsør E.F. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 2000, 60:4932-4938.
25. Rofstad E.K., Wahl A., Davies C.L., Brustad T. Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts. Cell Tissue Kinet. 1986, 19:205-216.
26. Rofstad E.K., Tunheim S.H., Mathiesen B., Graff B.A., Halsør E.F., Nilsen K., Galappathi K. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res. 2002, 62:661-664.
27. Rofstad E.K., Galappathi K., Mathiesen B., Ruud E.B. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin. Cancer Res. 2007, 13:1971-1978.
28. Rofstad E.K., Gaustad J.V., Egeland T.A., Mathiesen B., Galappathi K. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int. J. Cancer 2010, 127:1535-1546.
29. Sundfør K., Lyng H., Trope C.G., Rofstad E.K. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother. Oncol. 2000, 54:101-107.
30. Thews O., Wolloscheck T., Dillenburg W., Kraus S., Kelleher D.K., Konerding M.A., Vaupel P. Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. Br. J. Cancer 2004, 91:1181-1189.
31. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 1955, 9:539-549.
32. Tozer G.M., Ameer-Beg S.M., Baker J., Barber P.R., Hill S.A., Hodgkiss R.J., Locke R., Prise V.E., Wilson I., Vojnovic B. Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy. Adv. Drug Deliv. Rev. 2005, 57:135-152.
33. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989, 49:6449-6465.
34. Zhang L., Hill R.P. Hypoxia enhances metastatic efficiency by up-regulating Mdm2 in KHT cells and increasing resistance to apoptosis. Cancer Res. 2004, 64:4180-4189.